Patients’ and Physicians’ Preferences for Systemic Psoriasis Treatments: A Nationwide Comparative Discrete Choice Experiment (PsoCompare)

Patients’ and Physicians’ Preferences for Systemic Psoriasis Treatments: A Nationwide Comparative Discrete Choice Experiment (PsoCompare)

Systemic antipsoriatic treatment options are increasing rapidly. The aim of this nationwide discrete choice experiment was to compare patients’ (n = 222) and physicians’ (n = 78) preferences for outcome and process attributes of systemic antipsoriatics using Relative Importance Scores (RIS). Both gr...

Full description

Bibliographic Details
Main Authors:	Marthe-Lisa Schaarschmidt, Raphael Herr, Mandy Gutknecht, Katharina Wroblewska, Sascha Gerdes, Michael Sticherling, Matthias Augustin, Wiebke K. Peitsch
Format:	Article
Language:	English
Published:	Medical Journals Sweden 2017-11-01
Series:	Acta Dermato-Venereologica
Subjects:	biologicals conjointanalysis discretechoiceexperiment preferences psoriasis systemictreatment
Online Access:	https://www.medicaljournals.se/acta/content/html/10.2340/00015555-2834

Similar Items

Preferences of older patients regarding hip fracture rehabilitation service configuration: A feasibility discrete choice experiment
by: Joanna M. Charles, et al.
Published: (2018-05-01)

Patient preferences for topical psoriasis treatments: a discrete choice experiment
by: Suna Hoelker, et al.
Published: (2022-07-01)

Treatment satisfaction of patients with psoriasis with topical therapy in a real-world setting: unmet need for higher effectiveness
by: Nadia Ninosu, et al.
Published: (2023-12-01)

Analyzing the value of an educational program for psoriasis patients: a prospective controlled pilot study
by: Corinna Bubak, et al.
Published: (2019-11-01)

Measuring the importance of health domains in psoriasis – discrete choice experiment versus rating scales
by: Gutknecht M, et al.
Published: (2018-03-01)

Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis)
by: Luigi Gargiulo, et al.
Published: (2023-08-01)

Corrigendum: Treatment Satisfaction of Patients with Psoriasis
by: Marthe-Lisa Schaarschmidt, et al.
Published: (2022-12-01)

Comparative study of clinical and dermoscopic features in nail psoriasis
by: Naphisabet Wanniang, et al.
Published: (2020-01-01)

Implementation of the PsoWell™ Model for the Management of People with Complex Psoriasis
by: Rachael M. Hewitt, et al.
Published: (2021-04-01)

Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study—IL PSO (Italian landscape psoriasis)
by: Luigi Gargiulo, et al.
Published: (2023-07-01)

Patient Preferences for Treatment of Psoriasis with Biologicals: A Discrete Choice Experiment.
by: Christian Kromer, et al.
Published: (2015-01-01)

Real-world outcomes and drug survival of brodalumab: results from the German Psoriasis Registry PsoBest
by: Lisa Schaeffer, et al.
Published: (2024-12-01)

The comparative analysis of dermatoscopy picture of lichen planus and psoriasis
by: Sherstobitova K.Yu., et al.
Published: (2016-09-01)

PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries
by: Anna Langenbruch, et al.
Published: (2023-08-01)

Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients.
by: Marthe-Lisa Schaarschmidt, et al.
Published: (2015-01-01)

Comparing psoriasis advertisement methods with patient willingness to initiate treatment
by: Jeremy K. Bray, et al.
Published: (2020-08-01)

Absolute and relative psoriasis area and severity index (PASI) treatment goals and their association with health-related quality of life
by: Sascha Gerdes, et al.
Published: (2020-07-01)

Metabolic syndrome in patients with psoriasis: A comparative study
by: Sristi Lakshmi, et al.
Published: (2014-01-01)

Severe Scalp Psoriasis Microbiome Has Increased Biodiversity and Relative Abundance of Pseudomonas Compared to Mild Scalp Psoriasis
by: Jin-Young Choi, et al.
Published: (2022-11-01)

Generalized pustular psoriasis (von Zumbusch)
by: Ricardo Romiti, et al.
Published: (2022-02-01)

Psoriasis in special localizations
by: Klaudia Dopytalska, et al.
Published: (2018-12-01)

Anti-IL17 and anti-IL23 biologic drugs for genital psoriasis: a single-center retrospective comparative study
by: Andrea Cortese, et al.
Published: (2023-05-01)

Characterization of responder groups to secukinumab treatment in moderate to severe plaque psoriasis
by: Andreas Pinter, et al.
Published: (2020-11-01)

Patient-reported Outcomes and Burden of Disease in Paediatric Patients with Psoriasis: Real-world Data from EU5 and US
by: Marieke M.B. Seyger, et al.
Published: (2023-04-01)

Low Pneumococcal Vaccination among Patients with Psoriasis in Germany: Results from Vac-Pso
by: Phoebe Wellmann, et al.
Published: (2022-06-01)

A Comparative Analysis of the Predictors, Extent and Impacts of Self-stigma in Patients with Psoriasis and Atopic Dermatitis
by: Sophie Schlachter, et al.
Published: (2023-04-01)

Comparative study of anti-inflammatory activity of zinc pyrition on a psoriasis laboratory model
by: Alexander S. Zhukov, et al.
Published: (2020-08-01)

The frequency of cigarette smoking in patients with psoriasis vulgaris: a comparative study
by: Ashkevari Sh, et al.
Published: (2011-07-01)

Childhood psoriasis: What is new and what is news
by: Sunil Dogra, et al.
Published: (2018-01-01)

Dermatologia comparativa: psoríase hiperceratósica Comparative dermatology: hyperkeratotic psoriasis
by: Bruna Duque Estrada, et al.
Published: (2007-08-01)

Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses – IL PSO (Italian landscape psoriasis)
by: Luigi Gargiulo, et al.
Published: (2024-01-01)

Comparative Study of Hematological Parameters and Biomarkers of Immunity and Inflammation in Patients with Psoriasis and Atopic Dermatitis
by: Mirjana Bakic, et al.
Published: (2023-09-01)

Significant Differences in the Bacterial Microbiome of the Pharynx and Skin in Patients with Psoriasis Compared with Healthy Controls
by: Malin Assarsson, et al.
Published: (2020-09-01)

Physician-reported Clinical Unmet Needs, Burden and Treatment Patterns of Paediatric Psoriasis Patients: A US and EU Real-world Evidence Study
by: Marieke M.B. Seyger, et al.
Published: (2022-02-01)

Successful Treatment of Refractory Palmoplantar Pustular Psoriasis With Apremilast: A Case Series
by: Sascha Ständer, et al.
Published: (2020-10-01)

Erythrodermic Psoriasis Managed with Risankizumab
by: Abdulmajeed Alajlan, et al.
Published: (2022-08-01)

Revisiting the question of psoriasis classification
by: A. E. Karamova, et al.
Published: (2021-12-01)

Erythrodermic psoriasis treated with apremilast
by: John Arcilla, et al.
Published: (2016-09-01)

Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi Arabia
by: Yazed AlRuthia, et al.
Published: (2023-12-01)

Epidemiology of moderate-to-severe psoriasis: a comparison between psoriasis patients treated with biological agents, conventional systemic drugs and topical agents
by: Emanuel Marques, et al.
Published: (2022-04-01)